World
Indonesia Kicks Off Third Phase of Sinovac’s Vaccine Testing
- Phase 3 trial of Sinovac’s shots starts among 1,600 volunteers
- Indonesia aims to begin commercial production early next year
Sinovac’s Covid-19 vaccine
Photographer: Nicolas Asfouri/AFP via Getty Images
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Indonesia began the third phase of a Covid-19 vaccine trial made by China’s Sinovac Biotech Ltd. with a target to begin commercial production in six months.